Medicus Pharma Ltd Stock Piotroski F Score

MDCX Stock  USD 2.75  0.05  1.79%   
This module uses fundamental data of Medicus Pharma to approximate its Piotroski F score. Medicus Pharma F Score is determined by combining nine binary scores representing 3 distinct fundamental categories of Medicus Pharma Ltd. These three categories are profitability, efficiency, and funding. Some research analysts and sophisticated value traders use Piotroski F Score to find opportunities outside of the conventional market and financial statement analysis.They believe that some of the new information about Medicus Pharma financial position does not get reflected in the current market share price suggesting a possibility of arbitrage. Check out Medicus Pharma Altman Z Score, Medicus Pharma Correlation, Medicus Pharma Valuation, as well as analyze Medicus Pharma Alpha and Beta and Medicus Pharma Hype Analysis.
  
Short and Long Term Debt is likely to rise to about 1.8 M in 2024, whereas Long Term Debt is likely to drop slightly above 515.3 K in 2024.
At this time, it appears that Medicus Pharma's Piotroski F Score is Inapplicable. Although some professional money managers and academia have recently criticized Piotroski F-Score model, we still consider it an effective method of predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
1.0
Piotroski F Score - Inapplicable
Current Return On Assets

N/A

Focus
Change in Return on Assets

N/A

Focus
Cash Flow Return on Assets

Negative

Focus
Current Quality of Earnings (accrual)

Decreasing

Focus
Asset Turnover Growth

N/A

Focus
Current Ratio Change

N/A

Focus
Long Term Debt Over Assets Change

Lower Leverage

Focus
Change In Outstending Shares

Increase

Focus
Change in Gross Margin

N/A

Focus

Medicus Pharma Piotroski F Score Drivers

The critical factor to consider when applying the Piotroski F Score to Medicus Pharma is to make sure Medicus is not a subject of accounting manipulations and runs a healthy internal audit department. So, if Medicus Pharma's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if Medicus Pharma's financial numbers are properly reported.
Current ValueLast YearChange From Last Year 10 Year Trend
Net DebtM1.5 M
Way Down
Slightly volatile
Total Current LiabilitiesM1.1 M
Notably Down
Slightly volatile
Total AssetsM1.9 M
Sufficiently Up
Very volatile
Total Current AssetsM1.9 M
Sufficiently Up
Very volatile

Medicus Pharma F Score Driver Matrix

One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to project the various growth rates. Understanding the correlation between Medicus Pharma's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Medicus Pharma in a much-optimized way.

About Medicus Pharma Piotroski F Score

F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.

Total Assets

1.99 Million

At this time, Medicus Pharma's Total Assets are fairly stable compared to the past year.

About Medicus Pharma Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Medicus Pharma Ltd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medicus Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medicus Pharma Ltd based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Medicus OTC BB Equity Analysis

When running Medicus Pharma's price analysis, check to measure Medicus Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicus Pharma is operating at the current time. Most of Medicus Pharma's value examination focuses on studying past and present price action to predict the probability of Medicus Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicus Pharma's price. Additionally, you may evaluate how the addition of Medicus Pharma to your portfolios can decrease your overall portfolio volatility.